StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
AXIC-A.ST$1.35-1.38%
Fair $1.35+0.0%

AXIC-A.ST

aXichem AB

Basic Materials / Specialty ChemicalsStockholm

$1.35

-0.02 (-1.38%)

Fairly Valued+0.0%Fair Value $1.35Fund rank 30/100 · Data gapFallback financials|
SA 35/D
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 21%

FCF escenarios

weak_data · normalized FCF $-18.0M · quality 60.3/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 24/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

35/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is -33.4%, below the 5% threshold
Thesis & Journal · AXIC-A.STLocal privado en este navegador · aXichem AB
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$92M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-33.4%

↓

Gross Margin

49.2%

↑

Debt/Equity

0.09

↓
52-Week Range$1
$1$4

TradingView lightweight chart

AXIC-A.ST price, volumen y niveles de valoración

Último $1.430Periodo -83.6%
Fair value: $1.355

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+54.4%

FCF CAGR

—

FCF margin

-86.7%

FCF / Net income

0.91x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $18.4M · net income $-17.6M · FCF $-16.0M

2022-FY → 2025-FY

Gross margin

49.2%-27.0% pts

Operating margin

-94.8%+195.7% pts

Net margin

-95.6%+249.1% pts

FCF margin

-86.7%+346.8% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$18.4M$18.4M$8.6M$1.8M$5.0M
Net Income$-17.6M$-17.6M$-17.8M$-20.8M$-17.3M
EBITDA$-12.6M$-12.6M$-11.6M$-13.5M$-11.0M
EPS-0.30-0.30-0.46-1.02-1.00
Gross Margin49.2%49.2%82.6%77.9%76.3%
Operating Margin-94.8%-94.8%-184.7%-957.3%-290.5%
Net Margin-95.6%-95.6%-207.9%-1150.4%-344.7%
Balance Sheet
Debt/Equity0.090.09—0.210.47
Current Ratio4.234.23———
Cash Flow
Free Cash Flow$-16.0M$-16.0M$-18.0M$-20.8M$-21.7M
Returns
ROE-33.4%-33.4%-25.4%-42.9%-42.8%
Valuation
P/B1.531.530.701.695.60
Growth & Yield
Revenue Growth115.2%115.2%373.7%-63.9%—
EPS Growth34.8%34.8%55.3%-2.1%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -47.8%

Total return

-47.8%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.46 → -0.30

Residual

-47.8%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-47.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.